InvestorsHub Logo
Followers 0
Posts 10
Boards Moderated 0
Alias Born 07/30/2016

Re: scottsmith post# 77280

Wednesday, 10/05/2016 7:36:05 AM

Wednesday, October 05, 2016 7:36:05 AM

Post# of 466987
This will allow AVXL to speed up the testing phase while minimizing the cost: "Anavex’s 32-patient Alzheimer’s study utilizing KEM® will enable systematic analysis of more data on each patient in the disease group, on par with similar studies of significantly larger size, while providing greater cost and time efficiency. '
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News